Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...

Disturbances in Heart Rhythm

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...

Mechanism of Cardiac Arrhythmias

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.

ECG Interpretation of Arrhythmias I: Sinus Arrhythmias

ECG Interpretation of Arrhythmias I: Sinus Arrhythmias

Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cardiac Resynchronisation Therapy in Patients with Moderate to Severe Heart Failure in Germany: A Cost-Utility Analysis of the Additional Defibrillator.

Applied health economics and health policy·2020

Same author

Does the origin of ablated premature ventricular contractions determine the level of left ventricular function improvement?

Kardiologia polska·2020

Same author

Impact of single versus double transseptal puncture on outcome and complications in pulmonary vein isolation procedures.

Cardiology journal·2020

Same author

Smart Watch Devices for Atrial Fibrillation Screening: It Has to Start Somewhere.

Journal of the American College of Cardiology·2020

Same author

Early Mortality After Catheter Ablation of Atrial Fibrillation.

Journal of the American College of Cardiology·2020

Same author

Dynamic changes in the signal-averaged electrocardiogram are associated with the long-term outcomes after ablation of ischemic ventricular tachycardia.

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing·2020

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice

Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice

Published on: May 23, 2021

Treating arrhythmias: an expert opinion.

Nikolaos Dagres¹, Philipp Sommer, Maria Anastasiou-Nana

¹University of Athens, Second University Cardiology Department , Attikon University Hospital, Rimini Haidari, Athens, Greece. nikolaosdagres@yahoo.de

Expert Opinion on Pharmacotherapy

|March 1, 2011

Summary

Recent advancements in arrhythmia treatment include new drugs for atrial fibrillation like dronedarone and vernakalant. Novel antithrombotic agents such as dabigatran and rivaroxaban also show promise in managing arrhythmias.

More Related Videos

Robotic Ablation of Atrial Fibrillation

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Related Experiment Videos

Last Updated: Jun 4, 2026

Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice

Analyzing Long-Term Electrocardiography Recordings to Detect Arrhythmias in Mice

Published on: May 23, 2021

Robotic Ablation of Atrial Fibrillation

Robotic Ablation of Atrial Fibrillation

Published on: May 29, 2015

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

Area of Science:

Cardiology
Pharmacology

Background:

Significant progress in treating arrhythmias, particularly atrial fibrillation, which impacts millions.
Atrial fibrillation management remains a key challenge in cardiovascular medicine.

Purpose of the Study:

To review recent, clinically relevant developments in arrhythmia treatment.
To focus on novel agents for atrial fibrillation management and antithrombotic therapies.

Main Methods:

Extensive PubMed search using relevant keywords.
Review of recent literature on pharmacological treatments for arrhythmias.
Focus on dronedarone, vernakalant, and antithrombotic advancements.

Main Results:

Dronedarone is a proposed first-choice drug for atrial fibrillation but less effective than amiodarone and carries risks in severe heart failure.
Vernakalant offers effective, rapid pharmacological conversion of atrial fibrillation.
New oral anticoagulants like dabigatran and rivaroxaban show efficacy in stroke reduction without increased bleeding.

Conclusions:

Novel pharmacological agents are emerging for atrial fibrillation and ventricular arrhythmias.
Dronedarone has specific contraindications and potential risks.
New antithrombotic treatments offer effective stroke prevention in atrial fibrillation patients.